Release Date: 31/01/19 10:42 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 369.07KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%